Aktis Oncology, Inc. Debt Securities, Available-for-sale, Amortized Cost
Aktis Oncology, Inc. (AKTS) had Debt Securities, Available-for-sale, Amortized Cost of $435.57 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-13
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $435.57M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $167.10M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $188.96M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-06-30 | $435.57M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $167.10M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $188.96M 10-Q · filed 2026-08-13 |